Indication

Arginase deficiency

Arginase deficiency, also known as hyperargininemia, is a rare autosomal recessive urea cycle disorder caused by pathogenic variants in the *ARG1* gene. Read more about Arginase deficiency

12 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Arginase deficiency therapies.

Showing 1–9 of 12 drugs

Filter & compare in the drug finder →Opens the drug finder with Arginase deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Arginase deficiency.

Arginase deficiency, also known as hyperargininemia, is a rare autosomal recessive urea cycle disorder caused by pathogenic variants in the *ARG1* gene.

Impairment of the arginase 1 enzyme disrupts hepatic nitrogen detoxification, leading to the toxic systemic accumulation of arginine and its metabolites, alongside variable or episodic hyperammonemia.

Unlike other urea cycle disorders that present catastrophically in the neonatal period, arginase deficiency typically manifests in early childhood with progressive neurological impairment.

Defining clinical features include progressive lower-limb spasticity or spastic paraplegia, loss of motor milestones and ambulation, developmental delay, cognitive regression, microcephaly, and seizures.

Personalize your experience

Follow Arginase deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it